Long-term safety of filgrastim (rhG-CSF) administration: application of haematopoietic growth factors in healthy individuals.
Standard
Long-term safety of filgrastim (rhG-CSF) administration: application of haematopoietic growth factors in healthy individuals. / Bacher, Ulrike; Zander, Axel R.
In: BRIT J HAEMATOL, Vol. 137, No. 1, 1, 2007, p. 78-80.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
Bacher, U & Zander, AR 2007, 'Long-term safety of filgrastim (rhG-CSF) administration: application of haematopoietic growth factors in healthy individuals.', BRIT J HAEMATOL, vol. 137, no. 1, 1, pp. 78-80. <http://www.ncbi.nlm.nih.gov/pubmed/17359374?dopt=Citation>
APA
Bacher, U., & Zander, A. R. (2007). Long-term safety of filgrastim (rhG-CSF) administration: application of haematopoietic growth factors in healthy individuals. BRIT J HAEMATOL, 137(1), 78-80. [1]. http://www.ncbi.nlm.nih.gov/pubmed/17359374?dopt=Citation
Vancouver
Bacher U, Zander AR. Long-term safety of filgrastim (rhG-CSF) administration: application of haematopoietic growth factors in healthy individuals. BRIT J HAEMATOL. 2007;137(1):78-80. 1.
Bibtex
@article{8dbd206cd3eb42d782149f0f89d867ee,
title = "Long-term safety of filgrastim (rhG-CSF) administration: application of haematopoietic growth factors in healthy individuals.",
author = "Ulrike Bacher and Zander, {Axel R.}",
year = "2007",
language = "Deutsch",
volume = "137",
pages = "78--80",
journal = "BRIT J HAEMATOL",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "1",
}
RIS
TY - JOUR
T1 - Long-term safety of filgrastim (rhG-CSF) administration: application of haematopoietic growth factors in healthy individuals.
AU - Bacher, Ulrike
AU - Zander, Axel R.
PY - 2007
Y1 - 2007
M3 - SCORING: Zeitschriftenaufsatz
VL - 137
SP - 78
EP - 80
JO - BRIT J HAEMATOL
JF - BRIT J HAEMATOL
SN - 0007-1048
IS - 1
M1 - 1
ER -
